Skip to main content

Table 2 Estimated R&D cost of a new drug FDA (US$ millions).

From: Establishing a reasonable price for an orphan drug

  Orphan drugs Non-orphan drugs % of orphans to non-orphans
All indications 501.2 2140.8 23.4
Oncology 511.6 2341.5 21.8
  1. Estimates have been calculated using data from 2015 novel drug approvals of FDA; Estimates for all indications include oncology products